The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Transforming growth factor-β: A therapeutic target for cancer
Open accessAbstract
Transforming growth factor-β (TGF-β) regulates cell growth and differentiation, apoptosis, cell motility, extracellular matrix production, angiogenesis, and cellular immunity. It has a paradoxical role in cancer. In the early stages it inhibits cellular transformation and prevents cancer progression. In later stages TGF-β plays a key role in promoting tumor progression through mainly 3 mechanisms: facilitating epithelial to mesenchymal transition, stimulating angiogenesis and inducing immunosuppression. As a result of its opposing tumor promoting and tumor suppressive abilities, TGF-β and its pathway has represented potential opportunities for drug development and several therapies targeting the TGF-β pathway have been identified. This review focuses on identifying the mechanisms through which TGF-β is involved in tumorigenesis and current therapeutics that are under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R. L., Itoh, S., Kawabata, M., Heldin, N., Heldin, C., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,796
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A., Lièvre, M., Thomas, C., Hinkal, G. W., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,725
Sanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221
Research works printed but not linked: 2
- 10.1016/j.ejca.2015.07.035 · DOI · Paper page
- 10.1172/JCI0215234 · DOI
Cited by
Sorted by citations
Items 101–200 of 277
Srinivasarao, D. A., Shah, S., Famta, P., Vambhurkar, G. B., Jain, N., Pindiprolu, S. K. S. S., Sharma, A., Kumar, R., Padhy, H. P., Kumari, M., et al. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01673-z · Cited by 25
He, J. N., Gao, Y., Jing, L., Yang, H., & Liu, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1489701 · Cited by 29
Small extracellular vesicle TGF-β in cancer progression and immune evasion
Hosseini, R., Hosseinzadeh, N., Asef‐Kabiri, L., Akbari, A., Ghezelbash, B., Sarvnaz, H., & Akbari, M. E. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00638-7 · Cited by 24
Mesaros, O., Jimbu, L., Neaga, A., Popescu, C., Berceanu, I., Tomuleasa, C., Fetică, B., & Zdrenghea, M. (2020) · Biomedicines · doi:10.3390/biomedicines8110516 · Cited by 21
Zou, H., Ming, B., Li, J., Xiao, Y., Lai, L., Gao, M., Xu, Y. X., Tan, Z., Gong, F., & Zheng, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641973 · Cited by 22
Chen, C., Fa, Y., Kuo, Y., Liu, Y., Lin, C., Wang, X., Lu, Y., Chiang, Y., Yang, C., Wu, L.-C., et al. (2023) · Advanced Science · doi:10.1002/advs.202204643 · Cited by 22
The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer
Moradi‐Marjaneh, R., Khazaei, M., Ferns, G. A., & Aghaee‐Bakhtiari, S. H. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190110150705 · Cited by 22
Weiß, A., Boehm, M., Egemnazarov, B., Grimminger, F., Pullamsetti, S. S., Kwapiszewska, G., & SCHERMULY, R. T. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14919 · Cited by 22
Viral Hepatitides, Inflammation and Tumour Microenvironment
Timperi, E., & Barnaba, V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_3 · Cited by 21
Mašlanková, J., Večurkovská, I., Rabajdová, M., Kaťuchová, J., Kička, M., Gayova, M., & Katuch, V. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i33.4744 · Cited by 21
TGFβ Signaling in the Tumor Microenvironment
Goulet, C. R., & Pouliot, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_6 · Cited by 20
Hsu, H.-W., Lin, T.-Y., Liu, Y., Yeh, J., & Hsu, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063238 · Cited by 20
Dynamics of inflammatory signals within the tumor microenvironment
Issa, H., Singh, L., Lai, K., Parusheva-Borsitzky, T., & Ansari, S. (2025) · World Journal of Experimental Medicine · doi:10.5493/wjem.v15.i2.102285 · Cited by 19
A cytokine in turmoil: Transforming growth factor beta in cancer
Boye, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111657 · Cited by 22
Li, L., Wen, Q., & Ding, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.905520 · Cited by 19
Synergistic combination of oncolytic virotherapy with CAR T-cell therapy
Ajina, A., & Maher, J. F. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.015 · Cited by 20
A narrative review of the relationship between TGF-β signaling and gynecological malignant tumor
Luo, F., Huang, Y., Li, Y., Zhao, X., Xie, Y., Zhang, Q., Mei, J., & Liu, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4879 · Cited by 18
Zeng, N., Guo, C., Wang, Y., Li, L., Chen, X., Gao, S., Jiang, F., & Cao, B. (2022) · Journal of Oncology · doi:10.1155/2022/1271378 · Cited by 16
Structure, unique biological properties, and mechanisms of action of transforming growth factor β
Zelisko, N., Lesyk, R., & Stoika, R. S. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107611 · Cited by 18
Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis
Miller, L. H., Qu, C., & Pauly, M. G. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.07.001 · Cited by 18
Cobalt exposure increases the risk of fibrosis of people living near E‑waste recycling area
Xue, K., Qian, Y., Wang, Z., Guo, C., Wang, Z., Li, X., Li, Z., & Wei, Y. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112145 · Cited by 17
Role of TGF-β signaling in the mechanisms of tamoxifen resistance
Николаевна, Б. Н., Дронова, Т. А., Erdyneeva, D. B., Анатольевна, Г. П., & Чердынцева, Н. В. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.09.005 · Cited by 17
Wang, W., Ye, Y., Zhang, X., Sun, W., & Bao, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13989 · Cited by 17
Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival
Hisada, Y., & Mackman, N. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321603 · Cited by 16
A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer
Piperigkou, Z., Mangani, S., Kremmydas, S., Koletsis, N. E., & Karamanos, N. K. (2025) · FEBS Journal · doi:10.1111/febs.70296 · Cited by 19
Lind, H., Hall, S. C., Strait, A. A., Goon, J. B., Aleman, J., Chen, S. M. Y., Karam, S. D., Young, C. D., Wang, J. H., & Wang, J. H. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217347 · Cited by 16
Pollard, B. S., Suckow, M. A., Wolter, W. R., Starr, J. M., Eidelman, O., Dalgard, C. L., Kumar, P., Battacharyya, S., Srivastava, M., Biswas, R., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00630 · Cited by 16
RASSF1A: A promising target for the diagnosis and treatment of cancer
Bin, Y., Ding, Y., Xiao, W., & Liao, A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.014 · Cited by 16
Gao, S., Pu, N., Yin, H., Li, J., Chen, Q., Yang, M., Lou, W., Chen, Y., Zhou, G., Li, C., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920953728 · Cited by 16
Antitumor Effects of Baicalein and Its Mechanism via TGFβ Pathway in Cervical Cancer HeLa Cells
Yu, G., Chen, L., Hu, Y., Yuan, Z., Luo, Y., & Xiong, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5527190 · Cited by 17
Chen, S., Xu, J., Yao, S., Hua, L., Feng, C., Lin, Z., huang, H., & Li, Y. (2020) · Journal of Cancer · doi:10.7150/jca.34902 · Cited by 16
Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma
Roane, B. M., Meza‐Perez, S., Katre, A. A., Goldsberry, W. N., Randall, T. D., Norian, L. A., Birrer, M. J., & Arend, R. C. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0412 · Cited by 15
Rahimi, A., Malakoutikhah, Z., Rahimmanesh, I., Ferns, G. A., Nedaeinia, R., Ishaghi, S. M. M., Dana, N., & Javanmard, S. H. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03134-y · Cited by 15
Farag, A. A. G., Ngeun, S. K., Kaneda, M., Aboubakr, M., & Tanaka, R. (2024) · Biomedicines · doi:10.3390/biomedicines12081923 · Cited by 15
Wen, L., & Han, Z. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-655 · Cited by 15
Ding, J., He, X., Luo, W., Zhou, W., Chen, R., Cao, G., Chen, B., & Xiong, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.801419 · Cited by 15
Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases
Villanueva, B., Cerdà, P., Torres-Iglesias, R., Rocamora, J. L. S., Figueras, A., Viñals, F., & Riera-Mestre, A. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.05.020 · Cited by 15
Chi, J., Bi, W., Lou, K., Ma, J., Wu, J., & Cui, Y. (2024) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeae006 · Cited by 14
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Lin, L., Roccuzzo, G., Yakymiv, Y., Marchisio, S., Ortolan, E., Funaro, A., Senetta, R., Pala, V., Bagot, M., de Masson, A., et al. (2025) · Cells · doi:10.3390/cells14040309 · Cited by 14
Melatonin and TGF-β-Mediated Release of Extracellular Vesicles
Piekarska, K., Bonowicz, K., Grzanka, A., Jaworski, Ł. M., Reiter, R. J., Slominski, A. T., Steinbrink, K., Kleszczyński, K., & Gagat, M. (2023) · Metabolites · doi:10.3390/metabo13040575 · Cited by 13
Rekowska, A. K., Obuchowska, K., Bartosik, M., Kimber-Trojnar, Ż., Słodzińska, M., Wierzchowska-Opoka, M., & Leszczyńska‐Gorzelak, B. (2023) · Cancers · doi:10.3390/cancers15092618 · Cited by 13
He, J. W., Wu, F., Li, J., Deng, Q., Chen, J., Li, P., Jiang, X., Yang, K., Xu, S., Jiang, Z., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.05.010 · Cited by 13
Hei, B., Liu, R., & Li, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27722 · Cited by 15
Huang, Y., Chen, L., Chen, Y., Zhou, S., Xie, X., Xie, J., Yu, M., & Chen, J. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123147 · Cited by 13
Natarajan, S., & Ranganathan, M. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1797779 · Cited by 13
The Suppression of Th1 Response by Inducing TGF-β1 From Regulatory T Cells in Bovine Mycoplasmosis
Sajiki, Y., Konnai, S., Goto, S., Okagawa, T., Ohira, K., Shimakura, H., Maekawa, N., Gondaira, S., Higuchi, H., Tajima, M., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.609443 · Cited by 13
Context Matters: Response Heterogeneity to Collagen-Targeting Approaches in Desmoplastic Cancers
Fuller, A. M., & Eisinger‐Mathason, T. S. K. (2022) · Cancers · doi:10.3390/cancers14133132 · Cited by 15
Świtalska, M., Filip‐Psurska, B., Milczarek, M., Psurski, M., Moszyńska, A., Dąbrowska, A. M., Gawrońska, M., Krzymiński, K., Bagiński, M., Bartoszewski, R., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17430 · Cited by 13
Molecular study of the proliferation process of beta cells derived from pluripotent stem cells
Akhavan, S., Tutunchi, S., Malmir, A., Ajorlou, P., Jalili, A., & Panahi, G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06892-y · Cited by 12
Kurowska, N., Strzałka‐Mrozik, B., Madej, M., Pająk, K., Kruszniewska‐Rajs, C., Kaspera, W., & Gola, J. M. (2022) · Cancers · doi:10.3390/cancers14081876 · Cited by 12
Unveiling the landscape of cytokine research in glioma immunotherapy: a scientometrics analysis
Zhang, H., Chen, Y., Jiang, X., Gu, Q., Yao, J., Wang, X., & Wu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1333124 · Cited by 13
A preliminary study of cytokine gene polymorphism effects on Saudi patients with colorectal cancer
Althubyani, S. A., ALKHURIJI, A. F., Alomar, S. Y., & El‐Khadragy, M. F. (2020) · Saudi Medical Journal · doi:10.15537/smj.2020.12.25543 · Cited by 12
Qiu, X., Ma, F., & Zhang, H.-X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/1690421 · Cited by 12
RetractedApplication of Pro-angiogenic Biomaterials in Myocardial Infarction
Liang, T., Liu, J., Liu, F., Su, X., Li, X., Zeng, J., Chen, F., Wen, H., Chen, Y., Tao, J., et al. (2024) · ACS Omega · doi:10.1021/acsomega.4c04682 · Cited by 11
Xu, L., Han, F., Zhu, L. W., Ding, W., Zhang, K., Kan, C., Hou, N., Li, Q., & Sun, X. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5496 · Cited by 11
Current landscape of miRNAs and TGF‐β signaling in lung cancer progression and therapeutic targets
Hussen, B. M., Saleem, S. J., Abdullah, S. R., Mohamadtahr, S., Hidayat, H. J., Rasul, M. F., Taheri, M. N., & Kiani, A. (2023) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2023.101929 · Cited by 10
Anticancer potential of Thymoquinone from Nigella sativa L.: An in-silico and cytotoxicity study
Ravi, Y., Vethamoni, P. I., Saxena, S. N., Kaviyapriya, M., Santhanakrishnan, V. P., Raveendran, M., Ashoka, N., Choudhary, S., VERMA, A. K., Harisha, C. B., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323804 · Cited by 13
Rahavi, H., Alizadeh‐Navaei, R., & Tehrani, M. (2023) · Immunotherapy · doi:10.2217/imt-2022-0079 · Cited by 11
Zhang, B., Zhu, Z., Zhang, X., Li, F., & Ding, A. (2022) · Translational Andrology and Urology · doi:10.21037/tau-21-1117 · Cited by 10
Paucarmayta, A., Taitz, H., Casablanca, Y., Rodriguez, G. C., Maxwell, G. L., Darcy, K. M., & Syed, V. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.07.36 · Cited by 9
RetractedHadi, N., Namazi, F., Ketabchi, F., Khosravian, F., Nateghi, B., Talebi, A., Baghi, M., Mianesaz, H., Zare, F., & Salehi, M. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154077 · Cited by 9
Dai, C., Cao, Y., Huang, F., & Wang, Y. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.41 · Cited by 9
Wu, W., Zhao, L., Huang, L., Qin, Y., Zhang, J., Zhang, J., & Yan, Q. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.987825 · Cited by 8
Rane, R., Li, F., Williams, A., Jayadev, A., Tran, N. L., Winkles, J. A., & Kim, G. B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1662238 · Cited by 8
Zhou, Z., Xu, J., Huang, N., Tang, J., Ma, P., & Cheng, Y. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s353762 · Cited by 8
Petersen, S. H., Badawy, K. A., Hopkins, R., Vu, D. L., Rahmani, M., Maia, S. M. P., & Connolly, J. E. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100730 · Cited by 8
Liu, M., Honjo, M., Yamagishi, R., Igarashi, N., Nakamura, N., Kurano, M., Yatomi, Y., Igarashi, K., & Aihara, M. (2022) · Biomolecules · doi:10.3390/biom12091231 · Cited by 8
Eghtedari, A. R., Vaezi, M. A., Safari, E., Salimi, V., Safizadeh, B., Babaheidarian, P., Abiri, A., Mahdinia, E., Mirzaei, A., Mokhles, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47996-8 · Cited by 8
Jiang, J., Zhou, H. L., Jiang, Q., Sun, L., & Deng, P. (2018) · Molecules · doi:10.3390/molecules23112824 · Cited by 8
Prognostic Value of TGF-β Expression in Bladder Cancer: A Systematic Review and Meta-analysis
Kianmehr, S., Vahabirad, M., Seghatoleslam, A., Sadeghi, E., Kiani, R., & Ghasemi, H. (2024) · Urology Research and Practice · doi:10.5152/tud.2024.24024 · Cited by 7
Kang, Y.-H., Wang, J., Lee, J., Hwang, S., Lee, N., & Son, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-02122-w · Cited by 7
Ding, X., Li, X., Chen, F., Wang, H., & Jiang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70023 · Cited by 7
Gungor, M. Z., Uysal, M., Öztürk, M., & Şentürk, Ş. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00704-z · Cited by 8
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway
Gao, Y., Li, Y., Liu, Z., Dong, Y., Yang, S., Wu, B., Xiao, M., Chen, C., Wen, Y., Chen, L., et al. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s407680 · Cited by 7
Sankarasubramanian, S., Pfohl, U., Regenbrecht, C. R. A., Reinhard, C., & Wedeken, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760705 · Cited by 7
Maia, L. P., Levi, Y. L. D. A. S., Silva, P. H. F., Wons, L. C., Pitelli, L. P., de Castro, J. G., Dólens, E. D. S., Gregório, D., Straioto, F. G., Santinoni, C. D. S., et al. (2022) · Journal of Periodontology · doi:10.1002/jper.22-0146 · Cited by 7
The TGF-β/UCHL5/Smad2 Axis Contributes to the Pathogenesis of Placenta Accreta
Hashimoto, K., Miyagawa, Y., Watanabe, S., Takasaki, K., Nishizawa, M., Yatsuki, K., Takahashi, Y. K., Kamata, H., Kihira, C., Hiraike, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813706 · Cited by 7
Kumari, P., Ansari, S. N., Kumar, R., Saini, A. K., & Mobin, S. M. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900315 · Cited by 7
Dillman, R. O., Nistor, G. I., & Poole, A. J. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1680239 · Cited by 6
Yang, L., Liu, Z., & Wen, T. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.02.09 · Cited by 7
Le, H. T. T., Murugesan, A., Candeias, N. R., Yli-Harja, O. P., & Kandhavelu, M. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0159 · Cited by 6
Zhao, Z., Wu, Y., Wang, Z., Xu, J., Wang, Y., & Zhao, Z. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01172-2 · Cited by 6
Hirata, N., Yamada, S., Yanagida, S., Ono, A., Yasuhiko, Y., & Kanda, Y. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00112 · Cited by 6
Akhtar, M. R., Mondal, M. N. I., & Rana, H. K. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101211 · Cited by 6
Ngeun, S. K., Shimizu, M., & Kaneda, M. (2024) · Biology · doi:10.3390/biology13020072 · Cited by 6
Sadri, S., Aghajani, A., Soleimani, H., Kalkhajeh, S. G., Nazari, H., Milan, P. B., Peyravian, N., Pezeshkian, Z., Kebria, M. M., Shirazi, F., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10988-y · Cited by 5
The effect of cancer cell-derived exosomal proteins on macrophage polarization: An in-depth review
Wadhonkar, K., Das, S., Subramanian, R., Sk, M. H., Singh, Y., & Baig, M. S. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114393 · Cited by 6
Dwidar, Z., Awadin, W. F., El‐Adl, M., Abomosallam, M., Elzeer, A. A., & Abdellatif, A. M. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00320-7 · Cited by 5
Targeting TGFβ Pathway in Adult Granulosa Cell Tumor: Opening Pandora's Box?
Bonilla, L., & Oza, A. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1605 · Cited by 5
Critical Steps in Epithelial-Mesenchymal Transition as Target for Cancer Treatment
Denisov, E. V., Jolly, M. K., Шубин, В. П., Цуканов, А. С., & Чердынцева, Н. В. (2020) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-32857-3_10 · Cited by 5
Ma, B., Li, T., Li, W., Yang, H., Zeng, Q., Pan, Z., Wang, K., Chen, Q., Xiong, C., & Zhou, Z. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.10.014 · Cited by 5
Cui, K., Gong, S., Bai, J., Xue, L., Li, X., & Wang, X. (2023) · International Wound Journal · doi:10.1111/iwj.14596 · Cited by 5
RetractedRobby, A. I., Jiang, S., Jin, E., & Park, S. Y. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344139 · Cited by 6
Transforming Growth Factor-β (TGF-β) in Human Skin during Aging
Gunin, A. G., & Golubtzova, N. N. (2019) · Advances in Gerontology · doi:10.1134/s2079057019030068 · Cited by 5
Ansar, S., & Vetrivel, U. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1898470 · Cited by 5
Faruk, E. M., Sabry, D., Morsi, A. A., El-din, Y. A., Taha, N. M., & Medhat, E. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04255-6 · Cited by 5
Possible New Histological Prognostic Index for Large B-Cell Lymphoma
Nitta, H., Takizawa, H., Mitsumori, T., Iizuka, H., Araki, Y., Fujishiro, M., Tomita, S., Kishikawa, S., Hashizume, A., Sawada, T., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196324 · Cited by 5
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma
Trojan, A., Lone, Y. C., Briceño, I., & Trojan, J. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673237968231106095141 · Cited by 5
Jin, H., Huang, C. P., Dong, Y., Xiong, Q., Wang, D., He, Z., Shang, Y., Shen, L., Ma, C., Wang, Z., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1665299 · Cited by 4
Vargas, V. I., Shultz, R. B., Laimo, F. A., Cullen, D. K., & Lee, H. H. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124206 · Cited by 4
Metadata
- Authors
- Haque, S., & Morris, J. C.
- Affiliations
- University of Cincinnati (US)
- Corresponding author
- Morris, John C.
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2017-06-16
- Volume
- 13
- Issue
- 8
- Pages
- 1741-1750
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- PMC
- PMC5557219
- OpenAlex
- W2621206827
- Cited by
- 276
- References
- 145
- Citations by year
- 2026: 19 · 2025: 33 · 2024: 30 · 2023: 49 · 2022: 36 · 2021: 44 · 2020: 33 · 2019: 23 · 2018: 6 · 2017: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Vaccines & Immunotherapeutics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- TGF-beta, TGF-beta signaling, tumor progression, epithelial-mesenchymal transition, tumor angiogenesis, immunosuppression, tumor suppression, drug development, TGF-β inhibitors
- MeSH terms
- Animals, Antibodies, Monoclonal, Antineoplastic Agents, Cell Differentiation, Humans, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Transforming Growth Factor beta, Oligonucleotides, Antisense, Apoptosis, Mice, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review